Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 2, 2014
Emerging Company Profile
Panoptes: Dual attack in uveitis
...Corporate partners: 4SC AG Number of employees: 3 Funds raised: €1.2 million ($1.6 million) Investors:
aws-Life Science Austria
...
Read More
BioCentury
|
Sep 30, 2013
Financial News
Panoptes Pharma completes venture financing
...Austria Business: Ophthalmic Date completed: 9/26/13 Type: Venture financing Raised: €1.2 million ($1.6 million) Investors:
aws-Life Science Austria
...
Read More
BioCentury
|
Sep 27, 2013
Financial News
Panoptes closes EUR1.2M seed round, in-licenses 4SC compound
...Pharma GmbH (Vienna, Austria) raised EUR 1.2 million ($1.6 million) in a seed round from
AWS-Life Science Austria
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Jun 2, 2014
Emerging Company Profile
Panoptes: Dual attack in uveitis
...Corporate partners: 4SC AG Number of employees: 3 Funds raised: €1.2 million ($1.6 million) Investors:
aws-Life Science Austria
...
Read More
BioCentury
|
Sep 30, 2013
Financial News
Panoptes Pharma completes venture financing
...Austria Business: Ophthalmic Date completed: 9/26/13 Type: Venture financing Raised: €1.2 million ($1.6 million) Investors:
aws-Life Science Austria
...
Read More
BioCentury
|
Sep 27, 2013
Financial News
Panoptes closes EUR1.2M seed round, in-licenses 4SC compound
...Pharma GmbH (Vienna, Austria) raised EUR 1.2 million ($1.6 million) in a seed round from
AWS-Life Science Austria
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page